Tumor Risk in Disorders of Sex Development

2010 ◽  
Vol 4 (4-5) ◽  
pp. 259-269 ◽  
Author(s):  
J. Pleskacova ◽  
R. Hersmus ◽  
J.W. Oosterhuis ◽  
B.A. Setyawati ◽  
S.M. Faradz ◽  
...  
2007 ◽  
Vol 21 (3) ◽  
pp. 480-495 ◽  
Author(s):  
Leendert H.J. Looijenga ◽  
Remko Hersmus ◽  
J. Wolter Oosterhuis ◽  
Martine Cools ◽  
Stenvert L.S. Drop ◽  
...  

Author(s):  
Kazuhisa Akiba ◽  
Keiko Aso ◽  
Yukihiro Hasegawa ◽  
Maki Fukami

Abstract Objectives 5α-reductase type 2 deficiency due to biallelic SRD5A2 variants is a common form of 46,XY disorders of sex development. Case presentation A Chinese neonate presented with ambiguous genitalia. He carried a homozygous likely_pathogenic SRD5A2 variant (c.650C>A, p.A217E). His apparently nonconsanguineous parents were heterozygotes for the variant. The variant has previously been identified in two Chinese patients. Our patient carried 14.2 Mb loss-of-heterogeneity regions distributed in the genome. The SRD5A2 variant in this family was invariably coupled with two polymorphisms in exon 1 and intron 1. In the patient, blood testosterone (T)/5α-dihydrotestosterone (5αDHT) ratios were elevated before and during mini puberty, and were higher when measured by liquid chromatography-tandem mass spectrometry (LC-MS/MS) than measured by conventional immune assays. Conclusions This study provides evidence for the founder effect of an SRD5A2 variant. Furthermore, our data indicate that there is a need to establish a new reference value for T/5αDHT ratios using LC-MS/MS.


2012 ◽  
Vol 8 (6) ◽  
pp. 576-584 ◽  
Author(s):  
Lyn S. Chitty ◽  
Pierre Chatelain ◽  
Katja P. Wolffenbuttel ◽  
Yves Aigrain

Sign in / Sign up

Export Citation Format

Share Document